A20 and A20-binding proteins as cellular inhibitors of nuclear factor- κB-dependent gene expression and apoptosis

Biochemical Pharmacology

Volumn 60, Issue 8, 2000, Pages 1143-1151

  Beyaert, Rudi ^a   Heyninck, Karen ^a   Van Huffel, Sofie ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

A20; Apoptosis; NF B; Protein protein interaction; Tumor necrosis factor; Zinc finger

Indexed keywords

BINDING PROTEIN; CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LATENT MEMBRANE PROTEIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TAX PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; VIRUS PROTEIN; ZINC FINGER PROTEIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTERIOSCLEROSIS; ENDOTHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; YEAST;

EID: 0034668204     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00404-4     Document Type: Article

References (77)

1. Meager A. Cytokine regulation of cellular adhesion molecule expression in inflammation. Cytokine Growth Factor Rev. 10:1999;27-39.
2. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
3. Grossmann M., Nakamura Y., Grumont R., Gerondakis S. New insights into the roles of ReL/NF-κB transcription factors in immune function, hemopoiesis and human disease. Int J Biochem Cell Biol. 31:1999;1209-1219.
4. Baichwal V.R., Baeuerle P.A. Activate NF-κB or die? Curr Biol. 7:1997;R94-R96.
5. Hatada E.N., Krappmann D., Scheidereit C. NF-κB and the innate immune response. Curr Opin Immunol. 12:2000;52-58.
6. Kumar S. Mechanisms mediating caspase activation in cell death. Cell Death Differ. 6:1999;1060-1066.
7. Anderson K.V. Toll signaling pathways in the innate immune response. Curr Opin Immunol. 12:2000;13-19.
8. Beyaert R., Cuenda A., Vanden Berghe W., Plaisance S., Lee J.C., Haegeman G., Cohen P., Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J. 15:1996;1914-1923.
9. Carpentier I., Declercq W., Malinin N.L., Wallach D., Fiers W., Beyaert R. TRAF2 plays a dual role in NF-κB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IκB kinase pathways. FEBS Lett. 425:1998;195-198.
10. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J Biol Chem. 273:1998;3285-3290.
11. Nemoto S., DiDonato J.A., Lin A. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase. Mol Cell Biol. 18:1998;7336-7343.
12. Baeuerle P.A. IκB-NF-κB structures At the interface of inflammation control . Cell. 95:1998;729-731.
13. Rothe M., Xiong J., Shu H.B., Williamson K., Goddard A., Goeddel D.V. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA. 93:1996;8241-8246.
14. Lee S.Y., Cho Y. TRAF interacting protein (TRIP) A novel component of the TNF-R- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation . J Exp Med. 185:1997;1275-1285.
15. Krikos A., Laherty C.D., Dixit V.M. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by κB elements. J Biol Chem. 267:1992;17971-17976.
16. Dixit V.M., Green S., Sarma V., Holzman L.B., Wolf F.W., O'Rourke K., Ward P.A., Prochownik E.V., Marks R.M. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem. 265:1990;2973-2978.
17. Cooper J.T., Stroka D.M., Brostjan C., Palmetshofer A., Bach F.H., Ferran C. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism. J Biol Chem. 271:1996;18068-18073.
18. Sarma V., Lin Z., Clark L., Rust B.M., Tewari M., Noelle R.J., Dixit V.M. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem. 270:1995;12343-12346.
19. Laherty C.D., Perkins N.D., Dixit V.M. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB. J Biol Chem. 268:1993;5032-5039.
20. Miller W.E., Mosialos G., Kieff E., Raab-Traub N. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-κB activation. J Virol. 71:1997;586-594.
21. Laherty C.D., Hu H.M., Opipari A.W., Wang F., Dixit V.M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor KB. J Biol Chem. 267:1992;24157-24160.
22. Sporn S.A., Eierman D.F., Johnson C.E., Morris J., Martin G., Ladner M., Haskill S. Monocyte adherence results in selective induction of novel genes sharing homology with mediators of inflammation and tissue repair. J Immunol. 144:1990;4434-4441.
23. Yurochko A.D., Liu D.Y., Eierman D., Haskill S. Integrins as a primary signal transduction molecule regulating monocyte immediate-early gene induction. Proc Natl Acad Sci USA. 89:1992;9034-9038.
24. Tewari M., Wolf F.W., Seldin M.F., O'Shea K.S., Dixit V.M., Turka L.A. Lymphoid expression and regulation of A20, an inhibitor of programmed cell death. J Immunol. 154:1995;1699-1706.
25. Codd J.D., Salisbury J.R., Packham G., Nicholson L.J. A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol. 187:1999;549-555.
26. Opipari A.W. Jr, Boguski M.S., Dixit V.M. The A20 cDNA induced by tumor necrosis factor α encodes a novel type of zinc finger protein. J Biol Chem. 265:1990;14705-14708.
27. Opipari A.W. Jr, Hu H.M., Yabkowitz R., Dixit V.M. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 267:1992;12424-12427.
28. Janicke R.U., Lee F.H., Porter A.G. Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor α in tumor cells. Mol Cell Biol. 14:1994;5661-5670.
29. Jaattela M., Mouritzen H., Elling F., Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol. 156:1996;1166-1173.
30. Slowik M.R., Min W., Ardito T., Karsan A., Kashgarian M., Pober J.S. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab Invest. 77:1997;257-267.
31. Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V.L., Agresti C., Levrero M. Nuclear factor κB-independent cytoprotective pathways originating at tumor necrosis factor re- ceptor-associated factor 2. J Biol Chem. 273:1998;31262-31272.
32. Hess S., Gottfried E., Smola H., Grunwald U., Schuchmann M., Engelmann H. CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line. Eur J Immunol. 28:1998;3594-3604.
33. De Valck D., Jin D.Y., Heyninck K., Van de Craen M., Contreras R., Fiers W., Jeang K.T., Beyaert R. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene. 18:1999;4182-4190.
34. Wissing D., Mouritzen H., Jaattela M. TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20. Free Radic Biol Med. 25:1998;57-65.
35. Heyninck K., Denecker G., De Valck D., Fiers W., Beyaert R. Inhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20. Anticancer Res. 19:1999;2863-2868.
36. Varani J., Dame M.K., Taylor C.G., Sarma V., Merino R., Kunkel R.G., Nunez G., Dixit V.M. Age-dependent injury in human umbilical vein endothelial cells Relationship to apoptosis and correlation with a lack of A20 expression . Lab Invest. 73:1995;851-858.
37. Fries K.L., Miller W.E., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol. 70:1996;8653-8659.
38. Hu X., Yee E., Harlan J.M., Wong F., Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood. 92:1998;2759-2765.
39. Zhang S.Q., Kovalenko A., Cantarella G., Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor RIP and A20 bind to NEMO (IKKγ) upon receptor stimulation . Immunity. 12:2000;301-311.
40. Song H.Y., Rothe M., Goeddel D.V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc Natl Acad Sci USA. 93:1996;6721-6725.
41. De Valck D., Heyninck K., Van Criekinge W., Vandenabeele P., Fiers W., Beyaert R. A20 inhibits NF-κB activation independently of binding to 14-3-3 proteins. Biochem Biophys Res Commun. 238:1997;590-594.
42. Ferran C., Stroka D.M., Badrichani A.Z., Cooper J.T., Wrighton C.J., Soares M., Grey S.T., Bach F.H. A20 inhibits NF-κB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 91:1998;2249-2258.
43. Heyninck K., De Valck D., Vanden Berghe W., Van Criekinge W., Contreras R., Fiers W., Haegeman G., Beyaert R. The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J Cell Biol. 145:1999;1471-1482.
44. Eliopoulos A.G., Stack M., Dawson C.W., Kaye K.M., Hodgkin L., Sihota S., Rowe M., Young L.S. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene. 14:1997;2899-2916.
45. Arenzana-Seisdedos F., Thompson J., Rodriguez M.S., Bachelerie F., Thomas D., Hay R.T. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol Cell Biol. 15:1995;2689-2696.
46. Klement J.F., Rice N.R., Car B.D., Abbondanzo S.J., Powers G.D., Bhatt P.H., Chen C.H., Rosen C.A., Stewart C.L. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol Cell Biol. 16:1996;2341-2349.
47. Arvelo M.B., Badrichani A.Z., Stroka D.M., Grey S.T., Bach F.H., Ferran C. A novel function for A20 in smooth muscle cells Inhibition of activation and proliferation . Transplant Proc. 31:1999;858-859.
48. De Valck D., Heyninck K., Van Criekinge W., Contreras R., Beyaert R., Fiers W. A20, an inhibitor of cell death, self-associates by its zinc finger domain. FEBS Lett. 384:1996;61-64.
49. Heyninck K., Beyaert R. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κB activation at the level of TRAF6. FEBS Lett. 442:1999;147-150.
50. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev. 12:1998;2821-2830.
51. Vincenz C., Dixit V.M. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem. 271:1996;20029-20034.
52. Fukushi M., Dixon J., Kimura T., Tsurutani N., Dixon M.J., Yamamoto N. Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression. FEBS Lett. 442:1999;83-88.
53. Gachon F., Peleraux A., Thebault S., Dick J., Lemasson I., Devaux C., Mesnard J.M. CREB-2, a cellular CRE-dependent transcription repressor, functions in association with Tax as an activator of the human T-cell leukemia virus type 1 promoter. J Virol. 72:1998;8332-8337.
54. Korioth F., Gieffers C., Maul G.G., Frey J. Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol. 130:1995;1-13.
55. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300.
56. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240.
57. Carpentier I., Beyaert R. TRAF1 is a TNF inducible regulator of NF-κB activation. FEBS Lett. 460:1999;246-250.
58. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269:1995;1424-1427.
59. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D.V., Mak T.W. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1997;715-725.
60. Duckett C.S., Thompson C.B. CD30-dependent degradation of TRAF2 Implications for negative regulation of TRAF signaling and the control of cell survival . Genes Dev. 11:1997;2810-2821.
61. Eliopoulos A.G., Blake S.M., Floettmann J.E., Rowe M., Young L.S. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J Virol. 73:1999;1023-1035.
62. Widmann C., Gibson S., Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem. 273:1998;7141-7147.
63. Rothe M., Pan M.G., Henzel W.J., Ayres T.M., Goeddel D.V. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
64. Lee J.I., Burckart G.J. Nuclear factor κB Important transcription factor and therapeutic target . J Clin Pharmacol. 38:1998;981-993.
65. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature. 396:1998;77-80.
66. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature. 403:2000;103-108.
67. Neurath M.F., Pettersson S., Meyer zum Buschenfelde K.H., Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med. 2:1996;998-1004.
68. Bondeson J., Foxwell B., Brennan F., Feldmann M. Defining therapeutic targets by using adenovirus Blocking NF-κB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators . Proc Natl Acad Sci USA. 96:1999;5668-5673.
69. Soares M.P., Muniappan A., Kaczmarek E., Koziak K., Wrighton C.J., Steinhauslin F., Ferran C., Winkler H., Bach F.H., Anrather J. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. J Immunol. 161:1998;4572-4582.
70. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376:1995;167-170.
71. Sha W.C., Liou H.C. Tuomanen El and Baltimore D, Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
72. Chu Z.L., Shin Y.A., Yang J.M., DiDonato J.A., Ballard D.W. IKKγ mediates the interaction of cellular IκB kinases with the tax transforming protein of human T cell leukemia virus type 1. J Biol Chem. 274:1999;15297-15300.
73. Grey S.T., Arvelo M.B., Hasenkamp W., Bach F.H., Ferran C. A20 inhibits cytokine-induced apoptosis and nuclear factor κB-dependent gene activation in islets. J Exp Med. 190:1999;1135-1146.
74. Bach F.H., Ferran C., Hechenleitner P., Mark W., Koyamada N., Miyatake T., Winkler H., Badrichani A., Candinas D., Hancock W.W. Accommodation of vascularized xenografts Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment . Nat Med. 3:1997;196-204.
75. Miyatake T., Koyamada N., Hancock W.W., Soares M.P., Bach F.H. Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients. Transplantation. 65:1998;1563-1569.
76. Hancock W.W., Buelow R., Sayegh M.H., Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med. 4:1998;1392-1396.
77. Bandres J.C., Ratner L. Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-κB and AP-1 in human T cells in vitro after T-cell receptor stimulation. J Virol. 68:1994;3243-3249.